Genetic Analysis AS (XSAT:GEAN)

Genetic Analysis AS Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	43	44	25	36	55	164
Market Cap Growth	32.93%	80.23%	-30.96%	-34.88%	-66.69%	-
Enterprise Value	26	34	22	32	21	101
Last Close Price	0.63	0.64	0.48	0.81	2.07	6.21
PS Ratio	2.24	2.28	1.22	1.55	2.49	11.93
PB Ratio	1.75	1.79	1.12	1.12	1.17	2.21
P/TBV Ratio	3.19	3.26	1.22	1.14	1.17	2.22
P/FCF Ratio	23.11	23.60	-	-	-	-
P/OCF Ratio	19.72	20.14	-	-	-	-
EV/Sales Ratio	1.22	1.78	1.09	1.38	0.98	7.33
EV/FCF Ratio	13.75	18.39	-	-	-	-
Debt / Equity Ratio	0.24	0.24	0.44	0.23	0.21	0.04
Debt / FCF Ratio	3.12	3.12	-	-	-	-
Net Debt / Equity Ratio	-0.65	-0.65	-0.16	-0.28	-0.37	-0.61
Net Debt / EBITDA Ratio	2.89	2.89	0.25	0.37	0.58	1.53
Net Debt / FCF Ratio	-8.60	-8.60	0.39	0.51	0.82	1.58
Asset Turnover	0.45	0.45	0.43	0.39	0.28	0.19
Inventory Turnover	6.00	6.00	2.89	2.79	1.90	0.60
Quick Ratio	1.60	1.60	1.75	1.70	2.54	5.50
Current Ratio	1.64	1.64	1.83	1.81	2.74	5.78
Return on Equity (ROE)	-46.05%	-46.05%	-54.21%	-62.57%	-48.65%	-48.87%
Return on Assets (ROA)	-14.85%	-14.85%	-18.89%	-25.39%	-23.82%	-25.94%
Return on Capital Employed (ROCE)	-33.60%	-33.60%	-47.40%	-64.00%	-54.70%	-39.30%
Earnings Yield	-24.10%	-23.60%	-58.64%	-66.47%	-54.82%	-18.17%
FCF Yield	4.33%	4.24%	-35.56%	-48.49%	-38.17%	-17.35%
Buyback Yield / Dilution	-41.67%	-41.67%	-70.99%	-4.61%	-0.07%	-45.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.